Navigation Links
Excess liver gene protects against high-fat diet

A gene that senses fat in the liver can modulate the consequences of eating a high-fat, Western diet, new research published in the May issue of Cell Metabolism reveals.

Mice with an excess of liver X receptor (LXRa), when fed a diet high in fat, remained free from the high cholesterol and blood vessel plaques exhibited by animals with the normal complement of receptors. Remarkably, in mice fed a normal, balanced diet, the excess receptors worsened blood lipid levels, the researchers reported.

The findings suggest that natural variation among individuals in the quantity of the liver receptors might lead to differences among them in their susceptibility to high cholesterol and heart disease in a manner dependent on diet. Furthermore, drugs that modulate LXRa activity may have potential as therapies for lipid disorders and atherosclerosis, the group said.

"The high-cholesterol, high-fat Western diet has abetted an epidemic of atherosclerotic cardiovascular disease, making it the leading cause of death in industrialized nations," said study senior author Mitchell Lazar, of the University of Pennsylvania School of Medicine. "Yet we know that some people are more susceptible than others to obesity and other problems of excess, suggesting that the interplay between genes and diet is important.

"Now we have a vivid example of a specific genetic alteration with opposite effects in different nutritional environments."

The researchers examined lipid metabolism and atherosclerosis in mice with an approximately 3-fold increase in the concentration of LXRa receptors in their livers. The mice also lacked a second gene that made them particularly prone to cardiovascular disease.

When fed normal mouse chow, mice with a greater than average number of the receptors exhibited a rise in blood cholesterol and triglyceride levels. In contrast, altered mice fed a high-fat, Western diet showed improvements in blood lipid levels and protection from atherosclerosis.

Further experimentation revealed that the increase in LXRa differentially regulated the expression of other important metabolic genes.

"Liver X receptors had emerged as key regulators of cholesterol and lipid metabolism," said Lazar. "The current study elucidates a previously unrecognized role for these liver receptors in the links between diet, serum lipids, and atherosclerosis."

Selective modulation of the LXR target genes in liver may therefore ameliorate high lipid levels and cardiovascular disease, the researchers said.

The researchers include Michael Lehrke, Corinna Lebherz, Segan Millington, Hong-Ping Guan, John Millar, Daniel J. Rader, James M. Wilson, and Mitchell A. Lazar of the University of Pennsylvania School of Medicine. This work was supported by NIH grants, the Penn Diabetes and Endocrinology Research Center, and a Bristol Myers Squibb Freedom to Discover Award in Metabolic Research. M.L. was supported by a Deutsche Forschungsgemeinschaft fellowship.

Lehrke, M., Lebherz, C, Millington, S., Guan, H.-P., Millar, J., Rader, D.J., Wilson, J.M., and Lazar, M.A. (2005). Diet-dependent cardiovascular lipid metabolism controlled by hepatic LXRalpha. Cell Metab. 1, 297-308.


'"/>

Source:Cell Press


Related biology news :

1. Too much of a good thing? Excess nutrients or water limit biodiversity
2. Scientists ID molecular switch in liver that triggers harmful effects of saturated and trans fats
3. New methods of gene delivery using lasers
4. UNC launches study of liver injury caused by drugs
5. Gene therapy cures inherited liver disease in rats
6. Mouse with designer liver has enhanced glucose tolerance, insulin response
7. Recombinant DNA technology may enable oral, rather than injectable, delivery of protein drugs
8. Self-assembled DNA buckyballs for drug delivery
9. Insulin pulses keep the liver lean
10. New research could help us deliver genes for new bone formation
11. “Hitchhiking?Viruses as Cancer Drug Delivery System
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:6/2/2016)... 2, 2016   The Weather Company , an IBM ... an industry-first capability in which consumers will be able to ... ask questions via voice or text and receive relevant information ... Marketers have long sought an advertising solution that ... be personal, relevant and valuable; and can scale across millions ...
(Date:5/24/2016)... May 24, 2016 Ampronix facilitates superior patient care by providing unparalleled technology ... LCD display is the latest premium product recently added to the range of products ... ... ... 3d Imaging- LCD Medical Display- Ampronix News ...
(Date:5/12/2016)... 2016 WearablesResearch.com , a brand of ... results from the Q1 wave of its quarterly wearables ... consumers, receptivity to a program where they would receive ... insurance company. "We were surprised to see ... Michael LaColla , CEO of Troubadour Research, "primarily because ...
Breaking Biology News(10 mins):
(Date:6/27/2016)... 27, 2016 /PRNewswire/ - BIOREM Inc. (TSX-V: BRM) ("Biorem" or ... its major shareholders, Clean Technology Fund I, LP and ... based venture capital funds which together hold ... a fully diluted, as converted basis), that they have ... entire equity holdings in Biorem to TUS Holdings Co. ...
(Date:6/27/2016)... ... June 27, 2016 , ... Cancer experts from Austria, Hungary, ... be a new and helpful biomarker for malignant pleural mesothelioma. Surviving Mesothelioma has ... it now. , Biomarkers are components in the blood, tissue or body ...
(Date:6/27/2016)... Raleigh, NC (PRWEB) , ... June 27, 2016 ... ... a mission to bring innovative medical technologies, services and solutions to the healthcare ... development and implementation of various distribution, manufacturing, sales and marketing strategies that are ...
(Date:6/27/2016)... 2016  Liquid Biotech USA ... a Sponsored Research Agreement with The University of ... from cancer patients.  The funding will be used ... with clinical outcomes in cancer patients undergoing a ... be employed to support the design of a ...
Breaking Biology Technology: